[2003] UKIAT 00015 C (Zimbabwe)
Date heard: 4 February 2003
Date notified: 25/06/2003
Between
And
Respondent
"She is generally keeping much better and is currently on Trizivir which is a combination of Zidovudine, Lamivudine and Abacavir. This she was required to take lifelong in order to remain in good health.
It would be extremely unlikely that S would be able to continue on her current therapy if she was to return to Zimbabwe. This would obviously have a significant impact on her life expectancy and likelihood that she would develop and (sic) AIDES related illness."
DR H H STOREY
VICE-PRESIDENT